LBA47 Osimertinib as adjuvant therapy in patients (pts) with resected EGFR-mutated (EGFRm) stage IB-IIIA non-small cell lung cancer (NSCLC): Updated results from ADAURAM. Tsuboi,Y-L. Wu,C. Grohe,T. John,M. Majem Tarruella, J. Wang,T. Kato,J.W. Goldman,S-W. Kim,C-J. Yu,H. Vinh Vu,G. Mukhametshina,C. Akewanlop,F. de Marinis,F.A. Shepherd,D. Urban,M. Stachowiak,A.L. Bolanos,X. Huang,R.S. HerbstAnnals of Oncology（2022）引用 5|浏览3暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
